NYLIM
TXG icon

New York Life Investment Management’s 10x Genomics TXG Stock Holding History

New York Life Investment Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,827
Closed -$406K – 1296
2024
Q1 		$406K Sell
10,827
-366
-3% -$16.1K ﹤0.01% 805
2023
Q4 		$626K Buy
+11,193
New +$487K 0.01% 762

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

New York Life Investment Management's TXG Position: Q2 2024 in Review

New York Life Investment Management sold out of 10x Genomics (TXG) in Q2 2024, closing a stake of 10,827 shares — an estimated $406K sold.

New York Life Investment Management first reported a position in TXG in Q4 2023 and held it in 2 quarters. The position peaked at $626K in Q4 2023. 261 funds tracked by Wall St. Rank hold TXG as of Q2 2024.

  • New York Life Investment Management reported no remaining 10x Genomics position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 10,827 10x Genomics shares in Q2 2024, an estimated $406K.
  • New York Life Investment Management first reported a position in 10x Genomics in Q4 2023 and held it in 2 quarters.
  • New York Life Investment Management's 10x Genomics position peaked at $626K in Q4 2023.
  • 261 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.